Concomitant 0 11 0 11 O
use 12 15 12 15 O
of 16 18 16 18 O
immunosuppression 19 36 19 36 B-treatment
therapies 37 46 37 46 I-treatment

Ferritin 0 8 47 55 B-clinical_variable
≥ 9 10 56 57 O
500 11 14 58 61 B-lower_bound
ng 15 17 62 64 I-lower_bound
/ 17 18 64 65 I-lower_bound
mL 18 20 65 67 I-lower_bound

IL-1 0 4 68 72 O
blockade 5 13 73 81 O
for 14 17 82 85 O
at 18 20 86 88 O
least 21 26 89 94 O
2 27 28 95 96 B-lower_bound
weeks 29 34 97 102 I-lower_bound
prior 35 40 103 108 I-lower_bound
to 41 43 109 111 O
enrollment 44 54 112 122 O
are 55 58 123 126 O
allowed 59 66 127 134 O
into 67 71 135 139 O
the 72 75 140 143 O
study 76 81 144 149 O

Patients 0 8 150 158 O
> 9 10 159 160 O
17 11 13 161 163 B-lower_bound
years 14 19 164 169 I-lower_bound
of 20 22 170 172 O
age 23 26 173 176 B-age

Patients 0 8 177 185 O
receiving 9 18 186 195 O
stable 19 25 196 202 O
doses 26 31 203 208 O
of 32 34 209 211 O
corticosteroids 35 50 212 227 B-treatment

Patients 0 8 228 236 O
suffering 9 18 237 246 O
from 19 23 247 251 O
familial 24 32 252 260 B-chronic_disease
hemophagocytic 33 47 261 275 I-chronic_disease
lymphohistiocytosis 48 67 276 295 I-chronic_disease
( 68 69 296 297 I-chronic_disease
f 69 70 297 298 I-chronic_disease
HLH 71 74 299 302 I-chronic_disease
) 74 75 302 303 I-chronic_disease

Patients 0 8 304 312 O
who 9 12 313 316 O
are 13 16 317 320 B-pregnancy
pregnant 17 25 321 329 I-pregnancy

Patients 0 8 330 338 O
with 9 13 339 343 O
genetic 14 21 344 351 O
diagnosis 22 31 352 361 O
of 32 34 362 364 B-treatment
NLRC4 35 40 365 370 I-treatment
- 40 41 370 371 I-treatment
MAS 41 44 371 374 I-treatment
mutation 45 53 375 383 I-treatment

Patients 0 8 384 392 O
≤ 9 10 393 394 O
17 11 13 395 397 B-upper_bound
years 14 19 398 403 I-upper_bound
of 20 22 404 406 O
age 23 26 407 410 B-age

Positive 0 8 411 419 O
test 9 13 420 424 O
for 14 17 425 428 O
or 18 20 429 431 O
prior 21 26 432 437 O
history 27 34 438 445 O
of 35 37 446 448 O
HIV 38 41 449 452 B-chronic_disease
, 41 42 452 453 O
Hepatitis 43 52 454 463 B-chronic_disease
B 53 54 464 465 I-chronic_disease
or 55 57 466 468 O
Hepatitis 58 67 469 478 B-chronic_disease
C 68 69 479 480 I-chronic_disease
( 70 71 481 482 O
serology 71 79 482 490 O
) 79 80 490 491 O

Women 0 5 492 497 B-gender
of 6 8 498 500 O
childbearing 9 21 501 513 O
potential 22 31 514 523 O
with 32 36 524 528 O
negative 37 45 529 537 O
urine 46 51 538 543 O
pregnancy 52 61 544 553 B-pregnancy
test 62 66 554 558 O
( 67 68 559 560 O
UPT 68 71 560 563 O
) 71 72 563 564 O
at 73 75 565 567 O
all 76 79 568 571 O
visits 80 86 572 578 O

XIAP 0 4 579 583 B-chronic_disease
deficiency 5 15 584 594 I-chronic_disease
( 16 17 595 596 O
caused 17 23 596 602 O
by 24 26 603 605 O
BIRC4 27 32 606 611 O
gene 33 37 612 616 O
mutation 38 46 617 625 O
) 46 47 625 626 O

a 0 1 627 628 O
history 2 9 629 636 O
of 10 12 637 639 O
pulmonary 13 22 640 649 B-chronic_disease
TB 23 25 650 652 I-chronic_disease
infection 26 35 653 662 I-chronic_disease
with 36 40 663 667 O
or 41 43 668 670 O
without 44 51 671 678 O
documented 52 62 679 689 O
adequate 63 71 690 698 O
therapy 72 79 699 706 O

current 0 7 707 714 O
or 8 10 715 717 O
previous 11 19 718 726 O
history 20 27 727 734 O
of 28 30 735 737 O
malignancy 31 41 738 748 B-cancer

disease 0 7 749 756 B-treatment
modifying 8 17 757 766 I-treatment
anti 18 22 767 771 I-treatment
rheumatic 23 32 772 781 I-treatment
drugs 33 38 782 787 I-treatment
( 39 40 788 789 I-treatment
DMARDs 40 46 789 795 I-treatment
) 46 47 795 796 I-treatment

mAIDAI 0 6 797 803 B-clinical_variable
≥4 7 9 804 806 O

persistent 0 10 807 817 O
elevation 11 20 818 827 O
of 21 23 828 830 O
CRP 24 27 831 834 B-clinical_variable
≥ 28 29 835 836 O
2x 30 32 837 839 B-lower_bound
ULN 33 36 840 843 I-lower_bound

